Could a new pill for schizophrenia pass its first human test?
NCT ID NCT06105151
First seen Aug 14, 2026 · Last updated Aug 14, 2026
Summary
This early-stage trial evaluates an experimental oral drug called VV119, which is being developed for schizophrenia. The study enrolls healthy volunteers to receive a single dose of VV119 or a placebo, with some participants taking it with food to see if meals affect how the drug is absorbed. Researchers will monitor safety, side effects, and how the drug moves through the body. This is a first step to determine if VV119 is safe enough to study further in people with schizophrenia.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- VV119, an experimental oral drug being tested for schizophrenia
- What this could lead to
- If successful, this early trial could pave the way for a new oral medication option for schizophrenia, potentially offering better tolerability or convenience.
- What could go wrong
- This is a very early phase 1 study in healthy people, not patients. It primarily checks safety and how the drug behaves, so it may not lead to an effective treatment, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Anding Hospital of Capital Medical University
Beijing, Beijing Municipality, 100088, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new daily pill offer safer Long-Term control of schizophrenia?
- Can an Anti-Seizure drug quiet the brain and sharpen thinking in schizophrenia?
- Can a dissolving film tame agitation in schizophrenia?
- Can a phone app teach the brain to read social cues?
- Can a gentle brain current silence voices that medication Can't?
- Can a web app get people moving in mental health residential care?